Summary
OncoNano Medicine announced a research collaboration with Gilead Sciences to evaluate OncoNano’s ON-BOARD™ encapsulation technology with Gilead’s drug candidate.

OncoNano Medicine announced a research collaboration with Gilead Sciences to evaluate OncoNano’s ON-BOARD™ encapsulation technology with Gilead’s drug candidate.
Meet the talented individuals who brought their expertise and dedication to this project. Their collaboration, insight, and commitment to excellence were instrumental in delivering impactful results for our clients.
Stay updated with the latest industry news.
Stay updated with the latest industry news.
Whether you're seeking guidance on a complex transaction, exploring investment banking possibilities, or looking for wealth management strategies, our team is here to help.
Provide your email to join our distribution list. By providing your email you consent to receive emails from Salem Partners Wealth Management.